1. Klauschen F, Andreeff M, Keilholz U, Dietel M, Stenzinger A. The combinatorial complexity of cancer precision medicine. Oncoscience. 2014;1:504.
2. Institute of Medicine (US) Roundtable on Value & Science-Driven Health Care. Redesigning the Clinical Effectiveness Research Paradigm: Innovation and Practice-Based Approaches: Workshop Summary. Olsen LA, McGinnis JM, eds. Washington, DC: The National Academies Press; 2010. http://www.ncbi.nlm.nih.gov/books/NBK51016/.
3. Bjerrum OJ. New safe medicines faster: a proposal for a key action within the European Unions’ 6th framework programme. Pharmacol Toxicol. 2000;86 (suppl 1):25–28.
4. EUFEPS. New Safe Medicines Faster. http://www.eufeps.org/NSMF. Accessed April 28, 2015.
5. Goldman M, Seigneuret N, Eichler HG. The Innovative Medicines Initiative: an engine for regulatory science. Nat Rev Drug Discov. 2015;14:1–2.